256 related articles for article (PubMed ID: 22337711)
21. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
Zipursky RB; Odejayi G; Agid O; Remington G
Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
[TBL] [Abstract][Full Text] [Related]
22. The evaluation and treatment of first-episode psychosis.
Sheitman BB; Lee H; Strous R; Lieberman JA
Schizophr Bull; 1997; 23(4):653-61. PubMed ID: 9366001
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
Bradford DW; Perkins DO; Lieberman JA
Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730
[TBL] [Abstract][Full Text] [Related]
24. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
[TBL] [Abstract][Full Text] [Related]
25. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
26. What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis.
Gray R; Deane K
J Psychiatr Ment Health Nurs; 2016 Mar; 23(2):108-15. PubMed ID: 26914866
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
Andrade C
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
[TBL] [Abstract][Full Text] [Related]
28. Are depot as effective as oral antipsychotics on first-episode psychosis?
Orus C; Aceituno D
Medwave; 2016 May; 16 Suppl 2():e6447. PubMed ID: 27218484
[TBL] [Abstract][Full Text] [Related]
29. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
[TBL] [Abstract][Full Text] [Related]
30. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
[TBL] [Abstract][Full Text] [Related]
31. The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review.
Grünwald LM; Duddy C; Byng R; Crellin N; Moncrieff J
BMC Psychiatry; 2021 Aug; 21(1):390. PubMed ID: 34348680
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic treatment: experiences of fully recovered service users.
Bjornestad J; Davidson L; Joa I; Larsen TK; Hegelstad WTV; Langeveld J; Veseth M; Melle I; Johannessen JO; Bronnick K
J Ment Health; 2017 Jun; 26(3):264-270. PubMed ID: 28602144
[TBL] [Abstract][Full Text] [Related]
33. Increasing medication adherence and income assistance access for first-episode psychosis patients.
Randall J; Chateau D; Bolton JM; Smith M; Katz L; Burland E; Taylor C; Nickel NC; Enns J; Katz A; Brownell M;
PLoS One; 2017; 12(6):e0179089. PubMed ID: 28591137
[TBL] [Abstract][Full Text] [Related]
34. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
35. The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
Alisauskiene R; Løberg EM; Gjestad R; Kroken RA; Jørgensen HA; Johnsen E
Nord J Psychiatry; 2019; 73(4-5):281-287. PubMed ID: 31140342
[No Abstract] [Full Text] [Related]
36. Discontinuing antipsychotic treatment after a first-episode of psychosis: Who, when and how?
Emsley R
Schizophr Res; 2018 Jul; 197():59-60. PubMed ID: 29129505
[No Abstract] [Full Text] [Related]
37. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis.
Gleeson JF; Alvarez-Jimenez M; Cotton SM; Parker AG; Hetrick S
Schizophr Res; 2010 Jun; 119(1-3):79-88. PubMed ID: 20347266
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis.
Wade M; Tai S; Awenat Y; Haddock G
Clin Psychol Rev; 2017 Feb; 51():75-95. PubMed ID: 27838461
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotics in adolescent-onset psychosis: a work in progress.
James AC; Broome MR
Lancet Psychiatry; 2017 Aug; 4(8):e16-e17. PubMed ID: 28748801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
